4 October 2018 - The Morrison Government will make a medication for severe inflammatory spinal arthritis more affordable when it is listed on the Pharmaceutical Benefits Scheme, saving patients more than $15,000 a year.

Almost 4,000 patients who suffer from active non-radiographic axial spondyloarthritis will benefit when Simponi® (Golimumab) becomes available on the PBS on December 1.

Patients who would have had to pay over $1,300 per script will only pay a maximum of $39.50 per script, or only $6.40 if they have a concession card.

The Morrison Government has also negotiated immediate compassionate access for patients, meaning those who need it most will have access to the medication without having to wait until it’s listed on the PBS.

Read Minister of Health press release